Accepted at 7:51 p.m. Apr, 30, 2024 by herstein.jacob
Author: thomas.holmes
Co-authors: herstein.jacob
Related Note: 1571329545418 4
Rationale for change

UWorld says dose reduction is 1st line, if persistent then add low-potency anti-psychotic
Source: UWorld - Step 2 16164

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Empty field
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
Empty field
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step2_v12::#Subjects::Neurology::11_Degenerative_Disorders::Parkinson_Disease::Management #AK_Step2_v12::#B&B::10_Neuro::03_Movement_Disorders::01_Parkinson's_Disease::Extra #AK_Step2_v12::#NBME #AK_Other::!AK_UpdateTags::AnKing_Image::AhmedA::Extrapyramidal_Symptoms #AK_Other::!AK_UpdateTags::AnKing_Image::!Subjects::Psychiatry::Extrapyramidal_symptoms #AK_Step2_v12::#OME_banner #AK_Other::!AK_UpdateTags::AnKing_Image::Mujeeb::Extrapyramidal_symptoms #AK_Step2_v12::#CMS::Psychiatry::Form_6 #AK_Step2_v12::!Shelf::#Cards_AnKing_Did::5psych #AK_Step2_v12::Original_decks::Dorian::psych::uw #AK_Step2_v12::#UWorld::Step::16051 #AK_Step2_v12::#UWorld::COMLEX::103278 #AK_Step2_v12::#UWorld::COMLEX::103189 #AK_Step2_v12::#UWorld::Step::16164 #AK_Step2_v12::#AMBOSS::C8aqKm #AK_Step2_v12::#Resources_by_rotation::Psych::uworld::dorian #AK_Step2_v12::#B&B::13_Psych::04_Psychopharmacology::02_Antipsychotics::Extra #AK_Step2_v12::#UWorld::COMLEX::102073 #AK_Step2_v12::#AMBOSS #AK_Step2_v12::!Shelf::Psych::no_dupes::only_step2 #AK_Step2_v12::#CMS::Psychiatry::Form_03 #AK_Step2_v12::#Subjects::Neurology::11_Degenerative_Disorders::Parkinson_Disease #AK_Other::#AK_Original_Decks::Step_2::Cheesy_Dorian_(M3) #AK_Other::!AK_UpdateTags::AnKing_Image::MS::Extrapyramidal_symptoms #AK_Step2_v12::#UWorld::Step::12152 #AK_Step2_v12::#FirstAid::09_Neuro::13_Movement_Disorders::02_Parkinson_Disease_and_Parkinsonis